We believe that when tumor cells present extracellular galectin-3 binding sites, although galectin-3 binding to the cell surface has no effect in the cell viability, its presence in the cell surface may interfere with cellular activation, regulating how cells respond to apoptotic stimulus. The gene discussed is LGALS3; the disease is neoplasm.